“Umeclidinium in patients with COPD: a randomised, placebo-controlled study.” Roopa Trivedi, Nathalie Richard, Rashmi Mehta and Alison Church. Eur Respir J 2014; 43: 72–81.


Source: Eur Respir J 2014; 44: 555
Journal Issue: August
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
“Umeclidinium in patients with COPD: a randomised, placebo-controlled study.” Roopa Trivedi, Nathalie Richard, Rashmi Mehta and Alison Church. Eur Respir J 2014; 43: 72–81.. Eur Respir J 2014; 44: 555

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
“Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies.” Geoffrey Chupp, Michel Laviolette, Lauren Cohn, Charlene McEvoy, Sandeep Bansal, Adrian Shifren, Sumita Khatri, G. Mark Grubb, Edmund McMullen, Racho Strauven and Joel N. Kline. Eur Respir J 2017; 50: 1700017.
Source: Eur Respir J, 50 (4) 1750017; 10.1183/13993003.50017-2017
Year: 2017



“Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial.” Gerard Muñoz, Javier de Gracia, Maria Buxó, Antonio Alvarez and Montserrat Vendrell. Eur Respir J 2018; 51: 1701926.
Source: Eur Respir J, 51 (4) 1751926; 10.1183/13993003.51926-2017
Year: 2018


“Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results”. Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder, Daniel Haverstock, Mila Trajanovic and Sanjay Sethi. Eur Respir J 2012; 40: 17–27.},
Source: Eur Respir J 2012; 40: 800
Year: 2012


“Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice.” Brigitte Benard, Valérie Bastien, Benjamin Vinet, Roger Yang, Maja Krajinovic and Francine M. Ducharme. Eur Respir J 2017; 50: 1700148.
Source: Eur Respir J, 50 (5) 1750148; 10.1183/13993003.50148-2017
Year: 2017



“Asthma inhaler adherence determinants in adults: systematic review of observational data.” Alexandra L. Dima, Gimena Hernandez, Oriol Cunillera, Montserrat Ferrer, Marijn de Bruin and the ASTRO-LAB group. Eur Respir J 2015; 45: 994–1018.
Source: Eur Respir J 2016; 47:1892
Year: 2016


“Community-acquired pneumonia in younger patients is an entity on its own.” Benjamin Klapdor, Santiago Ewig, Mathias W. Pletz, Gernot Rohde, Hartwig Schütte, Tom Schaberg and Tobias Welte for the CAPNETZ study group. Eur Respir J 2012; 39: 1156–1161.
Source: Eur Respir J 2012; 40: 1583
Year: 2012


“Pulmonary arterial hypertension in patients treated with interferon.” Laurent Savale, Caroline Sattler, Sven Günther, David Montani, Marie-Camille Chaumais, Swanny Perrin, Xavier Jaïs, Andrei Seferian, Roland Jovan, Sophie Bulifon, Florence Parent, Gérald Simonneau, Marc Humbert and Olivier Sitbon. Eur Respir J 2014; 44: 1627–1634.
Source: Eur Respir J 2015; 46: 1854
Year: 2015


“Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.” Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776–1784.
Source: Eur Respir J 2016; 48: 593
Year: 2016


“Advanced medical interventions in pleural disease.” Rahul Bhatnagar, John P. Corcoran, Fabien Maldonado, David Feller-Kopman, Julius Janssen, Philippe Astoul and Najib M. Rahman. Eur Respir Rev 2016; 25: 199–213.
Source: Eur Respir Rev 2016; 25: 360
Year: 2016


“Infertility in an adult cohort with primary ciliary dyskinesia: phenotype–gene association.” Gert Jan Vanaken, Laurence Bassinet, Mieke Boon, Rahma Mani, Isabelle Honoré, Jean-Francois Papon, Harry Cuppens, Martine Jaspers, Natalie Lorent, André Coste, Estelle Escudier, Serge Amselem, Bernard Maitre, Marie Legendre and Sophie Christin-Maitre. Eur Respir J 2017; 50: 1700314.
Source: Eur Respir J, 50 (6) 1750314; 10.1183/13993003.50314-2017
Year: 2017


“Quit attempts and tobacco abstinence in primary care patients: follow-up of a pragmatic, two-arm cluster randomised controlled trial on brief stop-smoking advice – ABC versus 5As”. Sabrina Kastaun, Wolfgang Viechtbauer, Verena Leve, Jaqueline Hildebrandt, Christian Funke, Stephanie Klosterhalfen, Diana Lubisch, Olaf Reddemann, Tobias Raupach, Stefan Wilm and Daniel Kotz. ERJ Open Res 2021; 7: 00224-2021.
Source: ERJ Open Res, 7 (4) 50224-2021; 10.1183/23120541.50224-2021
Year: 2021


“Cardiovascular disease and COPD: dangerous liaisons?” Klaus F. Rabe, John R. Hurst and Samy Suissa. Eur Respir Rev 2018; 27: 180057.
Source: Eur Respir Rev, 27 (150) 185057; 10.1183/16000617.5057-2018
Year: 2018


“Cladribine improves lung cysts and pulmonary function in a child with histiocytosis.” Ralph Epaud, Hubert Ducou Le Pointe, Sylvie Fasola, Sandra Ploussard, Celine Delestrain, Chiara Sileo and Jean Donadieu. Eur Respir J 2015; 45: 831–833.
Source: Eur Respir J 2016; 47: 692
Year: 2016


“Lung diffusing capacity for nitric oxide measured by two commercial devices: a randomised crossover comparison in healthy adults”. Thomas Radtke, Quintin de Groot, Sarah R. Haile, Marion Maggi, Connie C.W. Hsia and Holger Dressel. ERJ Open Res 2021; 7: 00193-2021.
Source: ERJ Open Res, 7 (3) 50193-2021; 10.1183/23120541.50193-2021
Year: 2021


“Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.” Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus and Marlies Wijsenbeek. Eur Respir J 2018; 52: 1800230.
Source: Eur Respir J, 52 (4) 1850230; 10.1183/13993003.50230-2018
Year: 2018


“ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.” Alyn H. Morice, Eva Millqvist, Kristina Bieksiene, Surinder S. Birring, Peter Dicpinigaitis, Christian Domingo Ribas, Michele Hilton Boon, Ahmad Kantar, Kefang Lai, Lorcan McGarvey, David Rigau, Imran Satia, Jacky Smith, Woo-Jung Song, Thomy Tonia, Jan W.K. van den Berg, Mirjam J.G. van Manen and Angela Zacharasiewicz. Eur Respir J 2020; 55: 1901136.
Source: Eur Respir J, 56 (5) 1951136; 10.1183/13993003.51136-2019
Year: 2020


“The effect of exacerbation history on outcomes in the IMPACT trial.” David M.G. Halpin, Mark T. Dransfield, MeiLan K. Han, C. Elaine Jones, Sally Kilbride, Peter Lange, David A. Lipson, David A. Lomas, Fernando J. Martinez, Steve Pascoe, Dave Singh, Robert Wise and Gerard J. Criner. Eur Respir J 2020; 55: 1901921.
Source: Eur Respir J, 55 (6) 1951921; 10.1183/13993003.51921-2019
Year: 2020



“Clean air in Europe: beyond the horizon?” Bert Brunekreef, Nino Künzli, Juha Pekkanen, Isabella Annesi-Maesano, Bertil Forsberg, Torben Sigsgaard, Menno Keuken, Francesco Forastiere, Maeve Barry, Xavier Querol and Roy M. Harrison. Eur Respir J 2015; 45: 7–10.
Source: Eur Respir J 2015; 45: 861
Year: 2015


“ERS and tobacco harm reduction.” Charlotta Pisinger, Elif Dagli, Filippos T. Filippidis, Linnea Hedman, Christer Janson, Stelios Loukides, Sofia Ravara, Isabel Saraiva and Jørgen Vestbo, the ERS Tobacco Control Committee, on behalf of the ERS. Eur Respir J 2019; 54: 1902009.
Source: Eur Respir J, 55 (1) 1952009; 10.1183/13993003.52009-2019
Year: 2020


“Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease.” Laurent Savale, Anoosha Habibi, François Lionnet, Bernard Maitre, Vincent Cottin, Xavier Jais, Ari Chaouat, Elise Artaud-Macari, Matthieu Canuet, Grégoire Prevot, Christelle Chantalat-Auger, David Montani, Olivier Sitbon, Fréderic Galacteros, Gérald Simonneau, Florence Parent, Pablo Bartolucci and Marc Humbert. Eur Respir J 2019; 54: 1900585.
Source: Eur Respir J, 55 (1) 1950843; 10.1183/13993003.50585-2019
Year: 2020